Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Effects of Luteolin on Diabetic Nephropathy in STZ‐Induced Diabetic Rats
Guoguang Wang, Xiao Lü, Wei Li, et al.
Evidence-based Complementary and Alternative Medicine (2011) Vol. 2011, Iss. 1
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

Antidiabetic Potential of Medicinal Plants and Their Active Components
Bahare Salehi, Athar Ata, N. V. Anil Kumar, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 551-551
Open Access | Times Cited: 589
Antidiabetic properties of dietary flavonoids: a cellular mechanism review
Ramachandran Vinayagam, Baojun Xu
Nutrition & Metabolism (2015) Vol. 12, Iss. 1
Open Access | Times Cited: 528
Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
Li Li, Wu Luo, Yuanyuan Qian, et al.
Phytomedicine (2018) Vol. 59, pp. 152774-152774
Closed Access | Times Cited: 201
Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL function
Courtney Millar, Quinn Duclos, Christopher N. Blesso
Advances in Nutrition (2017) Vol. 8, Iss. 2, pp. 226-239
Open Access | Times Cited: 170
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
Qi Jin, Tong‐Tong Liu, Yuan Qiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 122
Dietary Luteolin: A Narrative Review Focusing on Its Pharmacokinetic Properties and Effects on Glycolipid Metabolism
Zhenyu Wang, Maomao Zeng, Zhaojun Wang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 5, pp. 1441-1454
Closed Access | Times Cited: 120
A natural products solution to diabetic nephropathy therapy
Qichao Hu, Lan Jiang, Qi Yan, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108314-108314
Closed Access | Times Cited: 71
Antioxidant Strategies in the Management of Diabetic Neuropathy
Ayodeji B. Oyenihi, Ademola Olabode Ayeleso, Emmanuel Mukwevho, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-15
Open Access | Times Cited: 168
Therapeutic approaches to diabetic nephropathy—beyond the RAS
Beatriz Fernández‐Fernández, Alberto Ortíz, Carmen Gómez‐Guerrero, et al.
Nature Reviews Nephrology (2014) Vol. 10, Iss. 6, pp. 325-346
Closed Access | Times Cited: 165
Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats
Dong Kwon Yang, Hyung‐Sub Kang
Biomolecules & Therapeutics (2018) Vol. 26, Iss. 2, pp. 130-138
Open Access | Times Cited: 161
Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract
Snehal N. Mestry, Jayesh B. Dhodi, Sangita Balbhim Kumbhar, et al.
Journal of Traditional and Complementary Medicine (2016) Vol. 7, Iss. 3, pp. 273-280
Open Access | Times Cited: 154
Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy
Goru Santosh Kumar, Apoorva Kulkarni, Amit Khurana, et al.
Chemico-Biological Interactions (2014) Vol. 223, pp. 125-133
Closed Access | Times Cited: 133
Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy
Sahabuddin Ahmed, Nitin Mundhe, Manash P. Borgohain, et al.
Inflammation (2016) Vol. 39, Iss. 5, pp. 1783-1797
Closed Access | Times Cited: 109
Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy
Saikat Dewanjee, Pratik Chakraborty, Biswajit Mukherjee, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2217-2217
Open Access | Times Cited: 108
Luteolin protects against lead acetate-induced nephrotoxicity through antioxidant, anti-inflammatory, anti-apoptotic, and Nrf2/HO-1 signaling pathways
Alaa Jameel A. Albarakati, Roua S. Baty, Ahmad M. Aljoudi, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 4, pp. 2591-2603
Closed Access | Times Cited: 104
Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-O-β-D-glucoside
Phiwayinkosi V. Dludla, Elizabeth Joubert, Christo J. F. Muller, et al.
Nutrition & Metabolism (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 95
Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes
Suchitra Kumari Panigrahy, Renu Bhatt, Awanish Kumar
Journal of drug targeting (2016) Vol. 25, Iss. 2, pp. 93-101
Closed Access | Times Cited: 94
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
Qichao Hu, Caiyan Qu, Xiaolin Xiao, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 74
Flavonoids in Treatment of Chronic Kidney Disease
Yiling Cao, Jihong Lin, Hans‐Peter Hammes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2365-2365
Open Access | Times Cited: 52
Therapeutic potential of Hyoscyamus niger-derived compounds: Targeting ovarian cancer through antioxidant activity and EGFR tyrosine kinase inhibition
Sabrina Lekmine, Ouided Benslama, Kenza Kadi, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 3, pp. 103103-103103
Open Access | Times Cited: 10
Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice
Ana Andres‐Hernando, Nanxing Li, Christina Cicerchi, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 85
Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases
Marcelo D. Catarino, Jorge M. Alves-Silva, Olívia R. Pereira, et al.
Current Topics in Medicinal Chemistry (2014) Vol. 15, Iss. 2, pp. 105-119
Open Access | Times Cited: 79
Protective Effect of Luteolin in Experimental Ischemic Stroke: Upregulated SOD1, CAT, Bcl-2 and Claudin-5, Down-Regulated MDA and Bax Expression
Huimin Qiao, Lipeng Dong, Xiangjian Zhang, et al.
Neurochemical Research (2012) Vol. 37, Iss. 9, pp. 2014-2024
Closed Access | Times Cited: 78
The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review
Zeinab Ashaari, Mousa-Al-Reza Hadjzadeh, Gholamreza Hassanzadeh, et al.
Journal of Molecular Neuroscience (2018) Vol. 65, Iss. 4, pp. 491-506
Closed Access | Times Cited: 72
Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages
Lei Zhang, Yijing Han, Xian Zhang, et al.
Diabetologia (2016) Vol. 59, Iss. 10, pp. 2219-2228
Open Access | Times Cited: 68
Page 1 - Next Page

Scroll to top